Marschall S. Runge Marschall S. Runge, MD, PhD
Dean, U-M Medical School
McKay Professor
Executive Vice President, Medical Affairs, University of Michigan
Chief Executive Officer, Michigan Medicine
About

The University of Michigan Board of Regents appointed Marschall S. Runge Executive Vice President for Medical Affairs and CEO of Michigan Medicine in March, 2015 and Dean of the Medical School in January, 2016. In this senior leadership role, he has responsibility for the health system and medical school as an executive officer of the university (EVPMA), and general oversight of the medical school as the Dean.

Before coming to U-M, Dr. Runge was executive dean for the University of North Carolina (UNC) School of Medicine, the Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine at UNC-Chapel Hill (UNC-CH), chair of the UNC-CH Department of Medicine, and principal investigator and director of the NIH-funded North Carolina Translational and Clinical Sciences (NC TraCS) Institute, one of 55 medical research institutions working together as a national consortium to improve the way biomedical research is conducted across the country.

An honors graduate of Vanderbilt University with a B.A. in Biology and a Ph.D. in Molecular Biology, Dr. Runge earned his M.D. from the Johns Hopkins School of Medicine, where he was an intern and resident in internal medicine. He then completed a cardiology fellowship at Harvard’s Massachusetts General Hospital and was a faculty member at Harvard.

Dr. Runge has been a physician-scientist for his entire career, combining basic and translational research with the care of patients with cardiovascular diseases and education. He is the author of over 200 publications in the field and holds five patents for novel approaches in healthcare.

Get to Know

What inspired you to pursue a career in this field?

I’ve always been drawn to the mystery of medicine. I’ve been a physician-scientist my entire career. This path has allowed me to work with patients, invent and patent novel approaches to care, and work with colleagues on research that can impact generations of people.

Why Michigan Medicine? Which attributes of this organization persuaded you to join us?

Our discoveries change care. Our care changes lives. By investing in research, education and patient care, we advance health to serve Michigan and the world. That’s what drew me to the University of Michigan.

What advice would you give others who wish to serve in a similar leadership role?

You can contribute in many ways but you’ll be most fulfilled if you focus on those areas you feel most passionate about.

Featured Articles 2025 Medical School Commencement selfie
Medical School News
To Medical School Class of 2025 graduates: Nurture leadership; call your parents
Many of our graduating medical students brought strong leadership skills with them to campus. Others have developed them through a flexible curriculum that has prepared them to be leaders and change agents in medicine. How, when and why they demonstrate leadership varies, but the featured speaker at the Medical School Commencement Ceremony on May 16 in Hill Auditorium told 163 graduating medical students that their leadership is welcome during a time of great turmoil in health care.
Smiling black and white photo of Phil Jenkins seated at his desk. He is dressed up in a button-up shirt and tie.
Philanthropy News
$3M Jenkins Foundation Gift Ensures Future of Depression Outreach Programs
Jenkins Foundation makes $3 million gift to the Kenneth and Frances Eisenberg and Family Depression Center to sustain outreach and community education programs.
2025 Dean's Lecture and Bold Science Symposium
Medical School News
2025 Dean’s Lecturer: GLP-1 therapies saving, improving lives of many patients
Lives are being saved, and many others are being changed dramatically, by current GLP-1 therapies like tirzepatide, which has helped many patients treat type 2 diabetes and sleep apnea, and also lose weight. It has been a long road from bench research to clinical trials to the health care market, but patients are now benefitting more than ever, according to a leading scientist who served as the keynote speaker for the second annual Dean’s Lecture and Bold Science Symposium, “Metabolism Research from Bench to Bedside.” Daniel Skovronsky, M.D., Ph.D., chief scientific officer and executive vice president of science and technology at Eli Lilly and Company and president of Research Laboratories and Lilly Immunology, was the Dean’s Lecturer on April 14 at the North Campus Research Complex Dining Hall.
Rendering of new Troy center for specialty care showing front of building and people walking on sidewalk
News Release
University of Michigan Health completes schematic design of new specialty care center in Troy
A new facility will allow U-M Health to expand specialty clinical services and increase patient access in Oakland County and across southeast Michigan.
Susan and Richard Rogel pose next to a grand piano. Rogel is wearing a polo shirt with a block M.
News Release
Rogel Cancer Center receives $50M gift to revolutionize pancreatic cancer care, research
New Rogel and Blondy Center for Pancreatic Cancer will bring together researchers and clinicians to drive forward new treatments and improve outcomes
Exterior buildings of University of Michigan Health-Sparrow in Lansing Michigan.
News Release
University of Michigan Health plans $32 million health care center in Grand Ledge
University of Michigan Health will build a new 45,000-square foot health care center near Grand Ledge, Michigan